全文获取类型
收费全文 | 2574篇 |
免费 | 258篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 44篇 |
儿科学 | 75篇 |
妇产科学 | 53篇 |
基础医学 | 271篇 |
口腔科学 | 89篇 |
临床医学 | 228篇 |
内科学 | 445篇 |
皮肤病学 | 18篇 |
神经病学 | 170篇 |
特种医学 | 310篇 |
外科学 | 476篇 |
综合类 | 105篇 |
一般理论 | 3篇 |
预防医学 | 154篇 |
眼科学 | 53篇 |
药学 | 199篇 |
中国医学 | 24篇 |
肿瘤学 | 124篇 |
出版年
2022年 | 12篇 |
2021年 | 31篇 |
2020年 | 18篇 |
2019年 | 27篇 |
2018年 | 38篇 |
2017年 | 39篇 |
2016年 | 32篇 |
2015年 | 29篇 |
2014年 | 57篇 |
2013年 | 119篇 |
2012年 | 157篇 |
2011年 | 139篇 |
2010年 | 89篇 |
2009年 | 75篇 |
2008年 | 124篇 |
2007年 | 149篇 |
2006年 | 115篇 |
2005年 | 110篇 |
2004年 | 95篇 |
2003年 | 93篇 |
2002年 | 93篇 |
2001年 | 80篇 |
2000年 | 67篇 |
1999年 | 63篇 |
1998年 | 74篇 |
1997年 | 64篇 |
1996年 | 45篇 |
1995年 | 39篇 |
1994年 | 34篇 |
1993年 | 36篇 |
1992年 | 34篇 |
1991年 | 43篇 |
1990年 | 37篇 |
1989年 | 52篇 |
1988年 | 46篇 |
1987年 | 49篇 |
1986年 | 48篇 |
1985年 | 48篇 |
1984年 | 32篇 |
1983年 | 44篇 |
1982年 | 21篇 |
1981年 | 20篇 |
1980年 | 19篇 |
1979年 | 19篇 |
1978年 | 20篇 |
1977年 | 17篇 |
1976年 | 25篇 |
1975年 | 13篇 |
1973年 | 9篇 |
1972年 | 10篇 |
排序方式: 共有2841条查询结果,搜索用时 15 毫秒
41.
Nuclear Cardiology for the past 40 years has distinguished itself in its ability to non-invasively assess regional myocardial blood flow and identify obstructive coronary disease. This has led to advances in managing the diagnosis, risk stratification, and prognostic assessment of cardiac patients. These advances have all been predicated on the collection of high quality nuclear image data. National and international professional societies have established guidelines for nuclear laboratories to maintain high quality nuclear cardiology services. In addition, laboratory accreditation has further advanced the goal of the establishing high quality standards for the provision of nuclear cardiology services. This article summarizes the principles of nuclear cardiology single photon emission computed tomography (SPECT) and positron emission tomography (PET) imaging and techniques for maintaining quality: from the calibration of imaging equipment to post processing techniques. It also will explore the quality considerations of newer technologies such as cadmium zinc telleride (CZT)-based SPECT systems and absolute blood flow measurement techniques using PET. 相似文献
42.
43.
T. Maishman H. Sheikh P. Boger J. Kelly K. Cozens A. Bateman S. Davies M. Fay D. Sharland A. Jackson 《Clinical oncology (Royal College of Radiologists (Great Britain))》2021,33(5):e225-e231
AimsSelf-expanding metal stents provide rapid improvement of dysphagia in oesophageal cancer but are associated with complications. The aim of the present study was to test the effectiveness of an alternative treatment of combining biodegradable stents with radiotherapy.Materials and methodsA Simon two-stage single-arm prospective phase II trial design was used to determine the efficacy of biodegradable stents plus radiotherapy in patients with dysphagia caused by oesophagus cancer who were unsuitable for radical treatment. Fourteen patients were recruited and data from 12 were included in the final analyses.ResultsFive of 12 patients met the primary end point: one stent-related patient death; four further interventions for dysphagia within 16 weeks of stenting (41.7%, 95% confidence interval 15.2–72.3%). The median time to a 10-point deterioration of quality of life was 2.7 weeks. Nine patients died within 52 weeks of registration. The median time to death from any cause was 15.0 weeks (95% confidence interval 9.6–not reached).ConclusionThe high re-intervention observed, which met the pre-defined early stopping criteria, meant that the suggested alternative treatment was not sufficiently effective to be considered for a larger scale trial design. Further work is needed to define the place of biodegradable stents in the management of malignant oesophageal strictures. 相似文献
44.
Autoimmune pancreatitis was first described in 1961, although it was not more widely recognized as an autoimmune condition until 1995. It has now become apparent that this form of pancreatitis is part of a clinical syndrome that is commonly multisystem in nature. One of the most common histopathological features is the presence of IgG4+ plasma cells within involved tissues. Many terms have been proposed to describe the condition, but 'IgG4-related systemic sclerosing disease' appears most appropriate. Commonly affected extrapancreatic tissues include the biliary tract, liver, kidneys and lung, but a wide range of other sites may be involved. Histological examination reveals features that are not entirely disease-specific, but that are often sufficiently characteristic to provide useful support to a clinicopathological diagnosis. The disease often responds well to systemic steroid therapy, unlike some of the conditions that it may simulate clinically. The emergence of this disease as a specific and treatable entity has favourably altered the clinical outlook for patients in whom steroid therapy might not previously have been considered appropriate. 相似文献
45.
S McKenna GA Evans Canadian Infectious Disease Society Antimicrobial Agents Committee 《The Canadian Journal of Infectious Diseases & Medical Microbiology》2001,12(4):218-231
Since the introduction of erythromycin in 1965, no new compounds from the macrolide antimicrobial class were licensed in Canada until the 1990s. Clarithromycin and azithromycin, since their introduction, have become important agents for treating a number of common and uncommon infectious diseases. They have become prime agents in the treatment of respiratory tract infections, and have revolutionized the management of both genital chlamydial infections, by the use of single-dose therapy with azithromycin, and nontuberculous mycobacterial infections, by the use of clarithromycin. The improvement of clarithromycin and azithromycin over the gastrointestinal intolerability of erythromycin has led to supplanting the use of the latter for many primary care physicians. Unfortunately, the use of these agents has also increased the likelihood for misuse and has raised concerns about a resultant increase in the rates of macrolide resistance in many important pathogens, such as Streptococcus pneumoniae. This paper reviews the pharmacology and evidence for the current indications for use of these newer agents, and provides recommendations for appropriate use.Key Words: Azithromycin, Clarithromycin, Erythromycin, Macrolides, Review, Therapeutic useErythromycin A is a naturally occurring, microbiologically active compound of the macrolide class of antibiotics. Chemical modification of erythromycin A''s 14-membered lactone ring has led to the formation of semisynthetic derivatives with not only improved bioavailability and tolerability, but also expanded spectrums of microbiological activity and improved pharmacokinetic profiles. Such modifications produced clarithromycin, classified as a macrolide because it retains the central 14-membered lactone ring (1,2), and azithromycin, classified as an azalide due to its 15-membered aglycone ring (1). The latter two compounds are the newest agents in the macrolide class licensed for use in Canada. Roxithromycin and dirithromycin are available in other countries.These compounds are clinically active against Gram-positive and Gram-negative cocci, and Gram-negative bacilli (primarily Haemophilus influenzae, Legionella species, Moraxella catarrhalis, Campylobacter jejuni, Bordatella pertussis and Helicobacter pylori). Azalides such as azithromycin have exhibited superior activity against Gram-negative pathogens and are generally less active against Gram-positive pathogens. Intracellular pathogens such as Chlamydia species, Mycoplasma species, Ureaplasma species, Borrelia species and nontuberculous mycobacteria species show varying susceptibilities. On the basis of their microbial activity, both the macrolides and azalides have been shown to be clinically useful in the treatment of uncomplicated skin and soft tissue infections, upper and lower respiratory tract infections, sexually transmitted Chlamydia trachomatis infection and peptic ulcer disease. Additionally, the improved pharmacokinetic profiles and acid stability exhibited by the newer agents may lead to enhanced patient adherence through less frequent dosing and improved bioavailability in the presence of food. 相似文献
46.
Manu Shankar-Hari Deepankar Datta Julie Wilson Valentina Assi Jacqueline Stephen Christopher J. Weir Jillian Rennie Jean Antonelli Anthony Bateman Jennifer M. Felton Noel Warner Kevin Judge Jim Keenan Alice Wang Tony Burpee Alun K. Brown Sion M. Lewis Tracey Mare Alistair I. Roy John Wright Gillian Hulme Ian Dimmick Alasdair Gray Adriano G. Rossi A. John Simpson Andrew Conway Morris Timothy S. Walsh 《Intensive care medicine》2018,44(11):1836-1848
Purpose
Reliable biomarkers for predicting subsequent sepsis among patients with suspected acute infection are lacking. In patients presenting to emergency departments (EDs) with suspected acute infection, we aimed to evaluate the reliability and discriminant ability of 47 leukocyte biomarkers as predictors of sepsis (Sequential Organ Failure Assessment score?≥?2 at 24 h and/or 72 h following ED presentation).Methods
In a multi-centre cohort study in four EDs and intensive care units (ICUs), we standardised flow-cytometric leukocyte biomarker measurement and compared patients with suspected acute infection (cohort-1) with two comparator cohorts: ICU patients with established sepsis (cohort-2), and ED patients without infection or systemic inflammation but requiring hospitalization (cohort-3).Results
Between January 2014 and February 2016, we recruited 272, 59 and 75 patients to cohorts 1, 2, and 3, respectively. Of 47 leukocyte biomarkers, 14 were non-reliable, and 17 did not discriminate between the three cohorts. Discriminant analyses for predicting sepsis within cohort-1 were undertaken for eight neutrophil (cluster of differentiation antigens (CD) CD15; CD24; CD35; CD64; CD312; CD11b; CD274; CD279), seven monocyte (CD35; CD64; CD312; CD11b; HLA-DR; CD274; CD279) and a CD8 T-lymphocyte biomarker (CD279). Individually, only higher neutrophil CD279 [OR 1.78 (95% CI 1.23–2.57); P?=?0.002], higher monocyte CD279 [1.32 (1.03–1.70); P?=?0.03], and lower monocyte HLA-DR [0.73 (0.55–0.97); P?=?0.03] expression were associated with subsequent sepsis. With logistic regression the optimum biomarker combination was increased neutrophil CD24 and neutrophil CD279, and reduced monocyte HLA-DR expression, but no combination had clinically relevant predictive validity.Conclusions
From a large panel of leukocyte biomarkers, immunosuppression biomarkers were associated with subsequent sepsis in ED patients with suspected acute infection.Clinical trial registration
NCT02188992.47.
The influence of topical anaesthetic agent at bronchoalveolar lavage upon cellular yield and identification and upon macrophage function 总被引:3,自引:0,他引:3
A C Davidson I Barbosa J S Kooner A S Hamblin T C Stokes N T Bateman B Gray 《British journal of diseases of the chest》1986,80(4):385-390
The influence of cocaine and lignocaine as local anaesthetic agent upon the results obtained at bronchoalveolar lavage was investigated. No differences were found. A functional activity of macrophages was assessed when the cells were stored in lavage fluid. A time-dependent decrease occurred which was related to lack of nutrients rather than the anaesthetic concentration. 相似文献
48.
49.
Ami E Iskandrian Timothy M Bateman Luiz Belardinelli Brent Blackburn Manuel D Cerqueira Robert C Hendel Hsiao Lieu John J Mahmarian Ann Olmsted S Richard Underwood Jo?o Vitola Whedy Wang 《Journal of nuclear cardiology》2007,14(5):645-658
BACKGROUND: Earlier phase 1 and 2 studies have shown that regadenoson has desirable features as a stress agent for myocardial perfusion imaging. METHODS AND RESULTS: This multicenter, double-blinded phase 3 trial involved 784 patients at 54 sites. Each patient underwent 2 sets of gated single photon emission computed tomography myocardial perfusion imaging studies: an initial qualifying study with adenosine and a subsequent randomized study with either regadenoson (2/3 of patients) or adenosine. Regadenoson was administered as a rapid bolus (<10 seconds) of 400 mug. The primary endpoint was to demonstrate noninferiority by showing that the difference in the strength of agreement in detecting reversible defects, based on blinded reading, between sequential adenosine-regadenoson images and adenosine-adenosine images, lay above a prespecified noninferiority margin. Other prospectively defined safety and tolerability comparisons and supporting analyses were also performed. The average agreement rate based on the median of 3 independent blinded readers was 0.63 +/- 0.03 for regadenoson-adenosine and 0.64 +/- 0.04 for adenosine-adenosine-a 1% absolute difference with the lower limit of the 95% confidence interval lying above the prespecified noninferiority margin. Side-by-side interpretation of regadenoson and adenosine images provided comparable results for detecting reversible defects. The peak increase in heart rate was greater with regadenoson than adenosine, but the blood pressure nadir was similar. A summed symptom score of flushing, chest pain, and dyspnea was less with regadenoson than adenosine (P = .013). CONCLUSIONS: This phase 3 trial shows that regadenoson provides diagnostic information comparable to a standard adenosine infusion. There were no serious drug-related side effects, and regadenoson was better tolerated than adenosine. 相似文献
50.
Anne M Fagan Rachel L Henson Yan Li Anna H Boerwinkle Chengjie Xiong Randall J Bateman Alison Goate Beau M Ances Eric Doran Bradley T Christian Florence Lai H Diana Rosas Nicole Schupf Sharon Krinsky-McHale Wayne Silverman Joseph H Lee William E Klunk Benjamin L Handen Ira T Lott 《Lancet neurology》2021,20(8):615-626